SG82014A1 - The use of aryl-cyclohexylamine derivatives against cns disorders - Google Patents

The use of aryl-cyclohexylamine derivatives against cns disorders

Info

Publication number
SG82014A1
SG82014A1 SG9903973A SG1999003973A SG82014A1 SG 82014 A1 SG82014 A1 SG 82014A1 SG 9903973 A SG9903973 A SG 9903973A SG 1999003973 A SG1999003973 A SG 1999003973A SG 82014 A1 SG82014 A1 SG 82014A1
Authority
SG
Singapore
Prior art keywords
aryl
cns disorders
derivatives against
against cns
cyclohexylamine derivatives
Prior art date
Application number
SG9903973A
Other languages
English (en)
Inventor
Alanine Alexander
Buttelmann Bernd
Heitz Neidhart Marie-Paule
Pinard Emmanuel
Wyler Rene
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SG82014A1 publication Critical patent/SG82014A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
SG9903973A 1998-08-18 1999-08-16 The use of aryl-cyclohexylamine derivatives against cns disorders SG82014A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98115484 1998-08-18

Publications (1)

Publication Number Publication Date
SG82014A1 true SG82014A1 (en) 2001-07-24

Family

ID=8232474

Family Applications (1)

Application Number Title Priority Date Filing Date
SG9903973A SG82014A1 (en) 1998-08-18 1999-08-16 The use of aryl-cyclohexylamine derivatives against cns disorders

Country Status (24)

Country Link
US (1) US6184236B1 (hr)
JP (1) JP3455142B2 (hr)
KR (1) KR100341194B1 (hr)
CN (1) CN1141936C (hr)
AR (1) AR021770A1 (hr)
AT (1) ATE326219T1 (hr)
AU (1) AU756408B2 (hr)
BR (1) BR9903779A (hr)
CA (1) CA2280455A1 (hr)
DE (1) DE69931316D1 (hr)
HR (1) HRP990256A2 (hr)
HU (1) HUP9902737A3 (hr)
ID (1) ID23107A (hr)
IL (1) IL131399A0 (hr)
MA (1) MA26677A1 (hr)
MY (1) MY133133A (hr)
NO (1) NO993948L (hr)
NZ (1) NZ337243A (hr)
PE (1) PE20000955A1 (hr)
PL (1) PL334949A1 (hr)
SG (1) SG82014A1 (hr)
TR (1) TR199902015A2 (hr)
YU (1) YU38699A (hr)
ZA (1) ZA995212B (hr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003535851A (ja) * 2000-06-06 2003-12-02 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー 二環式シクロヘキシルアミン類およびそれらのｎｍｄａ受容体アンタゴニストとしての使用
CA2440284A1 (en) * 2001-03-08 2002-09-19 Emory University Ph-dependent nmda receptor antagonists
DE10153345A1 (de) * 2001-10-29 2003-05-08 Gruenenthal Gmbh Substituierte 1H-Chinoxalin-2-on-Verbindungen und substituierte 4-Aryl- und 4-Heteroarylcyclohexan-Verbindungen
US20070004805A1 (en) * 2005-07-01 2007-01-04 Navinta Llc Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate
CA2693032A1 (en) * 2007-06-29 2009-01-08 Emory University Nmda receptor antagonists for neuroprotection

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260318A (en) * 1990-10-16 1993-11-09 Basf Aktiengesellschaft Phenylpiperidylamines and drugs containing them
US5296485A (en) * 1991-03-31 1994-03-22 Basf Aktiengesellschaft Substituted N-phenylpiperidines and drugs therefrom
AU7335896A (en) * 1995-10-26 1997-05-15 Mitsubishi-Tokyo Pharmaceuticals, Inc. Phenylethanolamine compounds useful as beta3 agonist, process for producing the same, and intermediates in the production of the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE130851T1 (de) 1991-03-14 1995-12-15 Basf Ag Substituierte n-phenylpiperidine und arzneimittel daraus.

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260318A (en) * 1990-10-16 1993-11-09 Basf Aktiengesellschaft Phenylpiperidylamines and drugs containing them
US5296485A (en) * 1991-03-31 1994-03-22 Basf Aktiengesellschaft Substituted N-phenylpiperidines and drugs therefrom
AU7335896A (en) * 1995-10-26 1997-05-15 Mitsubishi-Tokyo Pharmaceuticals, Inc. Phenylethanolamine compounds useful as beta3 agonist, process for producing the same, and intermediates in the production of the same

Also Published As

Publication number Publication date
MY133133A (en) 2007-10-31
AU4453799A (en) 2000-05-04
JP2000109429A (ja) 2000-04-18
ID23107A (id) 2000-02-24
HU9902737D0 (en) 1999-10-28
PL334949A1 (en) 2000-02-28
NZ337243A (en) 2000-12-22
AU756408B2 (en) 2003-01-09
AR021770A1 (es) 2002-08-07
DE69931316D1 (de) 2006-06-22
IL131399A0 (en) 2001-01-28
ATE326219T1 (de) 2006-06-15
HUP9902737A3 (en) 2001-01-29
NO993948L (no) 2000-02-21
NO993948D0 (no) 1999-08-17
HRP990256A2 (en) 2000-04-30
ZA995212B (en) 2000-02-18
CN1248439A (zh) 2000-03-29
HUP9902737A2 (hu) 2000-06-28
CN1141936C (zh) 2004-03-17
US6184236B1 (en) 2001-02-06
CA2280455A1 (en) 2000-02-18
TR199902015A3 (tr) 2000-03-21
JP3455142B2 (ja) 2003-10-14
TR199902015A2 (xx) 2000-03-21
PE20000955A1 (es) 2000-09-28
MA26677A1 (fr) 2004-12-20
YU38699A (sh) 2002-03-18
KR100341194B1 (ko) 2002-06-20
KR20000017343A (ko) 2000-03-25
BR9903779A (pt) 2000-09-19

Similar Documents

Publication Publication Date Title
HUP0104676A3 (en) Compositions for the treatment of anorectal disorders and their use
EP1063990A4 (en) THERAPY FOR ESTROGEN RELATED DISORDERS
ZA9810218B (en) Isoquinoline derivatives for use against cns disorders
HK1053058A1 (zh) 普拉克索用於治療成癮性疾病的用途
ZA200107689B (en) 1-Arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of CNS disorders.
HK1039124B (zh) 二氮雜萘衍生物磷酸二酯酶4抑制劑
AU2002215047A1 (en) Isoquinoline derivatives useful in the treatment of cns disorders
AU7388101A (en) Indole derivatives useful for the treatment of cns disorders
IL131399A0 (en) The use of aryl-cyclohexylamine derivatives against cns disorders
IL153605A0 (en) Indole derivatives useful for the treatment of cns disorders
IL153254A0 (en) Indole derivatives useful for the treatment of cns disorders
TW371925U (en) Structure of the caster
GB9816352D0 (en) The treatment of inflammatory disorders
GB9816349D0 (en) The treatment of inflammatory disorders
SI1049672T1 (en) Azetidinecarboxamide derivatives for treating cns disorders
SI1049670T1 (en) Azetidinecarboxamide derivatives for treating cns disorders
TW380671U (en) Improvement of the screw
HK1059086A1 (en) Indole derivatives useful for the treatment of cns disorders
IL153351A0 (en) Indole derivatives useful for the treatment of cns disorders
SI1305307T1 (en) Indole derivatives useful for the treatment of cns disorders
SI1294710T1 (en) Indole derivatives useful for the treatment of cns disorders
GB9824713D0 (en) Cognitive disorders
GB9824711D0 (en) Cognitive disorders
TW378743U (en) Preheating box of the shower
GB9816353D0 (en) The treatment of viral disorders